Drug-eluting stent and dual platelet aggregation: what we must know

Por Dr. Eduardo Nagib Gaui.

eduardo gaui

More articles by this author

Venus P-Valve: The valve and initial clinical worldwide experience

Por Dr. Alejandro Peirone.

FFR EM LESÕES SEQUENCIAIS E DOENÇA DIFUSA

Por Dr. Silvio Gioppato.  

Erros mais comuns na realização do FFR: como identificá-los e preveni-los

Por Dr. Fernando Mendes Sant’Anna.  

Análise Crítica do Estudo Leaders É o melhor stent que temos?

Por Dr. Esmeralci Ferreira.  

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...